The nervous system's tie to leukemia

Peter Gordon

Fifty years ago, only 10 percent of children with pediatric leukemia survived. Today, around 90 percent beat the disease.

In spite of these numbers, leukemia still devastates too many kids and families. That’s why Masonic Scholar Peter Gordon, M.D., Ph.D., a pediatrics faculty member and doctor at the U, is seeking ways to stop its progression.

One area that Gordon is exploring is how the central nervous system might contribute to the progression of acute lymphoblastic leukemia (ALL), as well as relapse and chemotherapy resistance in children with this cancer. It’s an understudied yet important aspect of leukemia research because ALL spreads to the nervous system in 50 percent of kids who do not receive nervous system therapy.  

In their past research, Gordon and his team discovered that ALL cells predominantly reside in a tissue called the meninges, which covers the brain and spinal cord, and that the ALL cells in this tissue are more resistant to chemotherapy.

This year, they made another big leap forward by identifying a drug that can re-sensitize leukemia cells in the meninges to chemotherapy. Their next big steps will be to further test this drug in the lab and in mouse models of central nervous system leukemia.

“Support from Minnesota Masonic Charities allows me to pursue research questions aimed at better understanding and, ultimately, treating leukemia."


Lisa Peterson
Chronic obstructive pulmonary diseases (COPDs) such as chronic bronchitis and emphysema make it difficult to breathe and can cause irreversible... Read more
Turesky researchers
Robert Turesky, inaugural holder of the Masonic Chair in Cancer Causation, is on a mission: to get cancer-causing chemicals in food, drinks, and... Read more
Andrew Nelson
Andrew Nelson, M.D., Ph.D., Masonic Scholar and laboratory medicine and pathology faculty member, is dedicated to understanding the biological... Read more